
Naim Alkhouri
@alkhourinaim
Chief Medical Officer (CMO). Director of the Steatotic Liver Program. Chief of Transplant Hepatology. Arizona Liver Health.
ID: 2157857058
27-10-2013 01:41:27
739 Tweet
2,2K Followers
1,1K Following

Huge day for patients with MASH. Our paper in Nature Med showing improved outcomes in cirrhotics w bariatric surgery and then akerotx showing reversal of cirrhosis!! So happy. Mazen Noureddin, MD, MHSc Ali Aminian Arizona Liver Health AASLD Foundation ACG nature.com/articles/s4159ā¦

Join us at the Scott Resort for the DASH for MASH as part of the Desert Liver Conference. Love the teaser video, we will make it a fun educational event with Mazen Noureddin, MD, MHSc and Anita Kohli . Madrigal Pharmaceuticals Nick Engelke Medscape Echosens akerotx HistoIndex

Thank you FattyLiverAlliance and Michael Betel for raising awareness about MASLD/ MASH/ SLD. The 3 Sās approach is more critical today than ever: Screen-Stage-Start Rx. Arizona Liver Health Mazen Noureddin, MD, MHSc Jeffrey V. Lazarus Juan Pablo (JP) Arab, MD īØ AASLD Madrigal Pharmaceuticals

Thank you Medscape Education and Medscape Gastro for organizing the Masters in MASH series. Join me and Zobair Younossi for the first episode on the burden of disease. More episodes scheduled in 2025 with Mazen Noureddin, MD, MHSc Jay H Shubrook Sr and others. Madrigal Pharmaceuticals Echosens Arizona Liver Health

Giving lectures in China has a different feeling:) despite the language barrier, the attendees were very engaged! Amazing food and friends as well:) Arizona Liver Health Mazen Noureddin, MD, MHSc Pinnacle Clinical Research Michael Betel Tony Villiotti Nick Engelke Sonal Kumar, MD MPH


Kicking off the AASLD ETC on SLD! Animal Models for MetALD are key for drug development. Mazen Noureddin, MD, MHSc Juan Pablo (JP) Arab, MD īØ Madrigal Pharmaceuticals EASL Education Yaron Rotman


Dr. Gene Im discussing definitions for MetALD! Itās ironic that this meeting about obesity and alcohol is in Las Vegas:) #AALSDETC AASLD Juan Pablo (JP) Arab, MD īØ Jeffrey V. Lazarus Mazen Noureddin, MD, MHSc Jeff Schwimmer Arizona Liver Health VCU Stravitz-Sanyal Institute for Liver Disease Rohit Kohli, MBBS, MSCI, FAASLD, NASPGHAN-F FattyLiverAlliance Fatty Liver Foundation Novo Nordisk


How to design trials for MetALD; the most relevant question at the AASLD ETC. Mazen Noureddin, MD, MHSc giving an outstanding presentation. EASL Education Yaron Rotman Juan Pablo (JP) Arab, MD īØ Rohit Kohli, MBBS, MSCI, FAASLD, NASPGHAN-F Arizona Liver Health Madrigal Pharmaceuticals Boehringer Ingelheim Galectin Thera: GALT


Thank you Scott Isaacs for highlighting our paper on cT1 prediction of histology response in MASH Perspectum . Arizona Liver Health FattyLiverAlliance Gene Im VCU Stravitz-Sanyal Institute for Liver Disease Mazen Noureddin, MD, MHSc

Kicking off the Desert Liver Conference DLC2025 with the NIT Summit. So happy to give the podium to different NIT companies to share their perspectives. Laurent Sandrin, the inventor of Fibroscan, giving an update. Echosens Mazen Noureddin, MD, MHSc Arizona Liver Health Pinnacle Clinical Research


Dr. Julio Gutierrez giving a master class on MASH future drugs. The future is bright:) Madrigal Pharmaceuticals Novo Nordisk Sagimet Biosciences akerotx Mazen Noureddin, MD, MHSc Arizona Liver Health Boehringer Ingelheim Jeffrey V. Lazarus Boston Pharma Sonal Kumar, MD MPH Scott Isaacs


Very excited to present at the premier Pathology meeting in the US #USCAP2025 #liverpath Arizona Liver Health Daniela Allende Mazen Noureddin, MD, MHSc HistoIndex Echosens Pinnacle Clinical Research Fatty Liver Foundation FattyLiverAlliance

One of the best reviews out there on GLP1RAs for MASLD. I'm biased of course, lol. Mazen Noureddin, MD, MHSc Sonal Kumar, MD MPH Novo Nordisk Eli Lilly and Company Boehringer Ingelheim Arizona Liver Health FattyLiverAlliance Fatty Liver Foundation American Gastroenterological Association (AGA) tandfonline.com/doi/full/10.10ā¦

Lovely experience presenting at the #USCAP2025 pathology meeting in Boston. Met some amazing hepato-pathologists. Thank you Dr. Maha Guindi for the invitation. HistoIndex Juan Pablo (JP) Arab, MD īØ Arizona Liver Health Pinnacle Clinical Research FattyLiverAlliance


Try out the ALADDIN calculator and provide feedback on its performance. So proud of the team, Dr. Winston Dunn, Mazen Noureddin, MD, MHSc Juan Pablo (JP) Arab, MD īØ Marco Arrese, MD Pinnacle Clinical Research. We will use in our clinics and trials soon. Madrigal Pharmaceuticals Echosens Boehringer Ingelheim aihepatology.shinyapps.io/ALADDIN2/

Early experience with resmetirom to treat MASH by Indiana University Gastroenterology and Hepatology pubmed.ncbi.nlm.nih.gov/40178494/ -High d/c rate due to GI AEs -Need close f/u early to manage GI AEs -Certainly not "prescribe & forget" like DAAs Madrigal Pharmaceuticals Raj VuppaLanchi Naim Alkhouri mazen noureddin Elliot Tapper


First time presenting at the Asembia pharmacy meeting. Asembia . Good to hear all the issues related to access. Madrigal Pharmaceuticals Novo Nordisk Echosens Pinnacle Clinical Research Mazen Noureddin, MD, MHSc #MASLD North Shore Gastro FattyLiverAlliance


It was great seeing some old colleagues at Digestive Disease Week . All doing exceptionally great things. Also nice to see all the new drugs for liver diseases making an impact:) Ashish Atreja Binu John Madrigal Pharmaceuticals Pinnacle Clinical Research Gene Im Novo Nordisk North Shore Gastro Mazen Noureddin, MD, MHSc


Great to see this great summary of our trial with Resmetirom in MASH cirrhosis. Madrigal Pharmaceuticals Pinnacle Clinical Research Mazen Noureddin, MD, MHSc Scott Isaacs Echosens Boehringer Ingelheim FattyLiverAlliance Arizona Liver Health North Shore Gastro Binu John Juan Pablo (JP) Arab, MD īØ

Kicking off the Global Think Tank on Steatotic Liver Disease #SLD in beautiful Barcelona. This is the āmost interactive meetingā in hepatology. Jƶrn Schattenberg Scott Isaacs FattyLiverAlliance Perspectum Echosens Madrigal Pharmaceuticals
